In this episode, Nazli Dizman and the Uromigos cover an update on the CBM588 probiotic strain and its phase II trial that combines the drug with ipilimumab and nivolumab to treat renal cancer. The data was presented at ASCO 2022.
The Uromigos Episode 175: Altering the Microbiome in Renal Cancer With CBM588
By The Uromigos - Last Updated: November 11, 2022
630 Madison Ave.
Manalapan, NJ 07726
© 2025 Mashup Media, LLC, a Formedics Property. All Rights Reserved.